198 related articles for article (PubMed ID: 26503172)
1. Choline kinase-α protein and phosphatidylcholine but not phosphocholine are required for breast cancer cell survival.
Mori N; Wildes F; Kakkad S; Jacob D; Solaiyappan M; Glunde K; Bhujwalla ZM
NMR Biomed; 2015 Dec; 28(12):1697-706. PubMed ID: 26503172
[TBL] [Abstract][Full Text] [Related]
2. Phospholipase D1 and choline kinase-α are interactive targets in breast cancer.
Gadiya M; Mori N; Cao MD; Mironchik Y; Kakkad S; Gribbestad IS; Glunde K; Krishnamachary B; Bhujwalla ZM
Cancer Biol Ther; 2014 May; 15(5):593-601. PubMed ID: 24556997
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive detection of lentiviral-mediated choline kinase targeting in a human breast cancer xenograft.
Krishnamachary B; Glunde K; Wildes F; Mori N; Takagi T; Raman V; Bhujwalla ZM
Cancer Res; 2009 Apr; 69(8):3464-71. PubMed ID: 19336572
[TBL] [Abstract][Full Text] [Related]
4. Characterization of choline kinase in human endothelial cells.
Mori N; Gadiya M; Wildes F; Krishnamachary B; Glunde K; Bhujwalla ZM
NMR Biomed; 2013 Nov; 26(11):1501-7. PubMed ID: 23775813
[TBL] [Abstract][Full Text] [Related]
5. Choline kinase overexpression increases invasiveness and drug resistance of human breast cancer cells.
Shah T; Wildes F; Penet MF; Winnard PT; Glunde K; Artemov D; Ackerstaff E; Gimi B; Kakkad S; Raman V; Bhujwalla ZM
NMR Biomed; 2010 Jul; 23(6):633-42. PubMed ID: 20623626
[TBL] [Abstract][Full Text] [Related]
6. Choline kinase down-regulation increases the effect of 5-fluorouracil in breast cancer cells.
Mori N; Glunde K; Takagi T; Raman V; Bhujwalla ZM
Cancer Res; 2007 Dec; 67(23):11284-90. PubMed ID: 18056454
[TBL] [Abstract][Full Text] [Related]
7. Selective inhibition of choline kinase simultaneously attenuates MAPK and PI3K/AKT signaling.
Yalcin A; Clem B; Makoni S; Clem A; Nelson K; Thornburg J; Siow D; Lane AN; Brock SE; Goswami U; Eaton JW; Telang S; Chesney J
Oncogene; 2010 Jan; 29(1):139-49. PubMed ID: 19855431
[TBL] [Abstract][Full Text] [Related]
8. Phorbol ester stimulation of phosphatidylcholine synthesis requires expression of both protein kinase C-alpha and phospholipase D.
Kiss Z; Crilly KS; Anderson WH
Biochim Biophys Acta; 1998 May; 1392(1):109-18. PubMed ID: 9593849
[TBL] [Abstract][Full Text] [Related]
9. Molecular causes of the aberrant choline phospholipid metabolism in breast cancer.
Glunde K; Jie C; Bhujwalla ZM
Cancer Res; 2004 Jun; 64(12):4270-6. PubMed ID: 15205341
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive imaging identifies new roles for cyclooxygenase-2 in choline and lipid metabolism of human breast cancer cells.
Shah T; Stasinopoulos I; Wildes F; Kakkad S; Artemov D; Bhujwalla ZM
NMR Biomed; 2012 May; 25(5):746-54. PubMed ID: 21953546
[TBL] [Abstract][Full Text] [Related]
11. Molecular Effects of Doxorubicin on Choline Metabolism in Breast Cancer.
Cheng M; Rizwan A; Jiang L; Bhujwalla ZM; Glunde K
Neoplasia; 2017 Aug; 19(8):617-627. PubMed ID: 28654865
[TBL] [Abstract][Full Text] [Related]
12. Phosphatidylcholine metabolism in nuclei of phorbol ester-activated LA-N-1 neuroblastoma cells.
Antony P; Kanfer JN; Freysz L
Neurochem Res; 2000 Aug; 25(8):1073-82. PubMed ID: 11055744
[TBL] [Abstract][Full Text] [Related]
13. Alterations of choline phospholipid metabolism in ovarian tumor progression.
Iorio E; Mezzanzanica D; Alberti P; Spadaro F; Ramoni C; D'Ascenzo S; Millimaggi D; Pavan A; Dolo V; Canevari S; Podo F
Cancer Res; 2005 Oct; 65(20):9369-76. PubMed ID: 16230400
[TBL] [Abstract][Full Text] [Related]
14. Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of the choline kinase inhibitor MN58b in human carcinoma models.
Al-Saffar NM; Troy H; Ramírez de Molina A; Jackson LE; Madhu B; Griffiths JR; Leach MO; Workman P; Lacal JC; Judson IR; Chung YL
Cancer Res; 2006 Jan; 66(1):427-34. PubMed ID: 16397258
[TBL] [Abstract][Full Text] [Related]
15. The phosphoinositide 3-kinase inhibitor PI-103 downregulates choline kinase alpha leading to phosphocholine and total choline decrease detected by magnetic resonance spectroscopy.
Al-Saffar NM; Jackson LE; Raynaud FI; Clarke PA; Ramírez de Molina A; Lacal JC; Workman P; Leach MO
Cancer Res; 2010 Jul; 70(13):5507-17. PubMed ID: 20551061
[TBL] [Abstract][Full Text] [Related]
16. Glycerophosphodiester phosphodiesterase domain containing 5 (GDPD5) expression correlates with malignant choline phospholipid metabolite profiles in human breast cancer.
Cao MD; Döpkens M; Krishnamachary B; Vesuna F; Gadiya MM; Lønning PE; Bhujwalla ZM; Gribbestad IS; Glunde K
NMR Biomed; 2012 Sep; 25(9):1033-42. PubMed ID: 22279038
[TBL] [Abstract][Full Text] [Related]
17. Metformin Decouples Phospholipid Metabolism in Breast Cancer Cells.
Smith TA; Phyu SM
PLoS One; 2016; 11(3):e0151179. PubMed ID: 26959405
[TBL] [Abstract][Full Text] [Related]
18. Molecular causes of elevated phosphoethanolamine in breast and pancreatic cancer cells.
Shah T; Krishnamachary B; Wildes F; Wijnen JP; Glunde K; Bhujwalla ZM
NMR Biomed; 2018 Aug; 31(8):e3936. PubMed ID: 29928787
[TBL] [Abstract][Full Text] [Related]
19. A novel small molecule antagonist of choline kinase-α that simultaneously suppresses MAPK and PI3K/AKT signaling.
Clem BF; Clem AL; Yalcin A; Goswami U; Arumugam S; Telang S; Trent JO; Chesney J
Oncogene; 2011 Jul; 30(30):3370-80. PubMed ID: 21423211
[TBL] [Abstract][Full Text] [Related]
20. Characterization of breast cancers and therapy response by MRS and quantitative gene expression profiling in the choline pathway.
Morse DL; Carroll D; Day S; Gray H; Sadarangani P; Murthi S; Job C; Baggett B; Raghunand N; Gillies RJ
NMR Biomed; 2009 Jan; 22(1):114-27. PubMed ID: 19016452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
